Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program. (Q40015220)
Jump to navigation
Jump to search
scientific article published on July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program. |
scientific article published on July 2008 |
Statements
Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program (English)
Peter J Houghton
Malcolm A Smith
John M Maris
Stephen T Keir
Hernan Carol
Christopher L Morton
Doris A Phelps